Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Clinical trial NCT00153101 · COMPLETED
Trial details
- NCT number
- NCT00153101
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-01
- Primary completion
- 2008-06-01
- Enrollment
- 31546
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.